Cargando…

Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells

In contrast to class I/IIb/pan histone deacetylase inhibitors (HDACi), the role of class IIa HDACi as anti-cancer chemosensitizing agents is less well understood. Here, we studied the effects of HDAC4 in particular and the class IIa HDACi CHDI0039 on proliferation and chemosensitivity in Cal27 and c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schrenk, Christian, Bollmann, Lukas M., Haist, Corinna, Bister, Arthur, Wiek, Constanze, Wecker, Maria, Roth, Dennis, Petzsch, Patrick, Köhrer, Karl, Hamacher, Alexandra, Hanenberg, Helmut, Fluegen, Georg, Kassack, Matthias U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056166/ https://www.ncbi.nlm.nih.gov/pubmed/36982651 http://dx.doi.org/10.3390/ijms24065553

Ejemplares similares

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells
por: Grunewald, Camilla M., et al.
Publicado: (2021)

The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines
por: Bollmann, Lukas M., et al.
Publicado: (2022)

A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells
por: Bister, Arthur, et al.
Publicado: (2021)

Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines
por: Bandolik, Jan J., et al.
Publicado: (2019)

Effects of novel HDAC inhibitors on urothelial carcinoma cells
por: Kaletsch, Aline, et al.
Publicado: (2018)

HDAC5 Expression in Urothelial Carcinoma Cell Lines Inhibits Long-Term Proliferation but Can Promote Epithelial-to-Mesenchymal Transition
por: Jaguva Vasudevan, Ananda Ayyappan, et al.
Publicado: (2019)

Development of the Korean Community Health Determinants Index (K-CHDI)
por: Go, Dun-Sol, et al.
Publicado: (2020)

Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1
por: Wang, Chenyin, et al.
Publicado: (2020)

Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies
por: Soldierer, Maren, et al.
Publicado: (2022)

Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo
por: Bister, A., et al.
Publicado: (2022)

Profiling the 3D interaction between germ cell tumors and microenvironmental cells at the transcriptome and secretome level
por: Skowron, Margaretha A., et al.
Publicado: (2022)

Class IIa HDACs in myelination
por: Velasco-Aviles, Sergio, et al.
Publicado: (2018)

Proteomic and transcriptomic profiles of human urothelial cancer cells with histone deacetylase 5 overexpression
por: Jaguva Vasudevan, Ananda Ayyappan, et al.
Publicado: (2022)

Understanding BRCA2 Function as a Tumor Suppressor Based on Domain-Specific Activities in DNA Damage Responses
por: Andreassen, Paul R., et al.
Publicado: (2021)

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039
por: Pałucha-Poniewiera, Agnieszka, et al.
Publicado: (2010)

EHMTI-0039. Different efficacy of acute migraine therapies for migraine with aura versus without aura
por: Hansen, J Møller, et al.
Publicado: (2014)

Longitudinal preclinical evaluation of the novel radioligand [11C]CHDI-626 for PET imaging of mutant huntingtin aggregates in Huntington’s disease
por: Bertoglio, Daniele, et al.
Publicado: (2021)

Comparative Genomics of the Baltic Sea Toxic Cyanobacteria Nodularia spumigena UHCC 0039 and Its Response to Varying Salinity
por: Teikari, Jonna E., et al.
Publicado: (2018)

Hydroxamic Acids Immobilized on Resins (HAIRs): Synthesis of Dual‐Targeting HDAC Inhibitors and HDAC Degraders (PROTACs)
por: Sinatra, Laura, et al.
Publicado: (2020)

Contingencies of UTX/KDM6A Action in Urothelial Carcinoma
por: Lang, Alexander, et al.
Publicado: (2019)

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors
por: Rodrigues Moita, Ana J., et al.
Publicado: (2020)

HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy
por: Hoerster, Keven, et al.
Publicado: (2021)

HDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma
por: Lee, Sang Wu, et al.
Publicado: (2021)

Inhibition of the function of class IIa HDACs by blocking their interaction with MEF2
por: Jayathilaka, Nimanthi, et al.
Publicado: (2012)

Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9
por: Lenoir, Olivia, et al.
Publicado: (2011)

In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using (11)C-CHDI-180R PET in a Nonhuman Primate Model of Huntington Disease
por: Bertoglio, Daniele, et al.
Publicado: (2023)

Erratum: Mattan et al., Motivation Modulates Brain Networks in Response to Faces Varying in Race and Status: A Multivariate Approach (eNeuro July/August 2018, 5(4) e0039-18.2018 1-13 https://doi.org/10.1523/ENEURO.0039-18.2018)
Publicado: (2018)

Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis
por: Clocchiatti, Andrea, et al.
Publicado: (2011)

Spotlight on CYP4B1
por: Röder, Annika, et al.
Publicado: (2023)

Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine
por: Dong, Chao, et al.
Publicado: (2016)

Gα(i3) signaling is associated with sexual dimorphic expression of the clock-controlled output gene Dbp in murine liver
por: Singh, Madhurendra, et al.
Publicado: (2018)

Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells
por: Wanek, Julia, et al.
Publicado: (2018)

Expression of histone deacetylase (HDAC) family members in bortezomib-refractory multiple myeloma and modulation by panobinostat
por: Cheng, Tiewei, et al.
Publicado: (2021)

Oxa Analogues of Nexturastat A Demonstrate Improved HDAC6 Selectivity and Superior Antileukaemia Activity
por: Pflieger, Marc, et al.
Publicado: (2021)

Class IIa HDACs regulate learning and memory through dynamic experience-dependent repression of transcription
por: Zhu, Yongchuan, et al.
Publicado: (2019)

Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity
por: Martin, Sheree D., et al.
Publicado: (2023)

A Novel MCPH1 Isoform Complements the Defective Chromosome Condensation of Human MCPH1-Deficient Cells
por: Gavvovidis, Ioannis, et al.
Publicado: (2012)

Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
por: Burmeister, Aaron, et al.
Publicado: (2022)

Insights into the Recruitment of Class IIa Histone Deacetylases (HDACs) to the SMRT/NCoR Transcriptional Repression Complex
por: Hudson, Gregg M., et al.
Publicado: (2015)

The mobile SAR signal N-hydroxypipecolic acid induces NPR1-dependent transcriptional reprogramming and immune priming
por: Yildiz, Ipek, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ebj75de7i438h1ad86d045opn1